Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
|
|
HALOZYME THERAPEUTICS, INC. (HALO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 1,925 shares
@ $42.407, valued at
$81.6k
Sold 8,075 shares
@ $42.407, valued at
$342.4k
Exercised 1,925 options to buy
@ $18.41, valued at
$35.4k
Exercised 8,075 options to buy
@ $19.98, valued at
$161.3k
|
|
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2023 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $43.711, valued at
$437.1k
Sold 10,000 shares
@ $43.741, valued at
$437.4k
|
|
| 07/27/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $42.796, valued at
$428k
Sold 10,000 shares
@ $42.689, valued at
$426.9k
Sold 10,000 shares
@ $43.79, valued at
$437.9k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
Exercised 10,000 options to buy
@ $13.87, valued at
$138.7k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2023 |
4
| Posard Matthew L. (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| Miyashita Akiko Moni (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| MATSUI CONNIE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| Henderson Jeffrey William (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/09/2023 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/09/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $45.469, valued at
$454.7k
Sold 10,000 shares
@ $43.259, valued at
$432.6k
Sold 10,000 shares
@ $42.727, valued at
$427.3k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 03/01/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 03/01/2023 |
4
| Henderson Jeffrey William (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $48.51, valued at
$485.1k
Sold 10,000 shares
@ $47.71, valued at
$477.1k
|
|
| 02/28/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 7,016 shares
@ $49.548, valued at
$347.6k
Sold 2,984 shares
@ $49.549, valued at
$147.9k
|
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
4
| LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,951 shares
@ $48.92, valued at
$144.4k
Paid exercise price by delivering 2,725 shares
@ $48.92, valued at
$133.3k
Exercised 8,133 restricted stock units
@ $0
Exercised 7,883 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,392 shares
@ $48.92, valued at
$68.1k
Paid exercise price by delivering 681 shares
@ $48.92, valued at
$33.3k
Exercised 2,503 restricted stock units
@ $0
Exercised 1,389 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 16,469 shares
@ $48.92, valued at
$805.7k
Paid exercise price by delivering 17,266 shares
@ $48.92, valued at
$844.7k
Exercised 31,281 restricted stock units
@ $0
Exercised 32,794 restricted stock units
@ $0 |
|
| 02/09/2023 |
4
| Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Sold 10,000 shares
@ $51.258, valued at
$512.6k
Sold 10,000 shares
@ $51.357, valued at
$513.6k
Sold 10,000 shares
@ $50.4, valued at
$504k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
Exercised 10,000 options to buy
@ $14.66, valued at
$146.6k
|
|
| 02/07/2023 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 1,188 shares
@ $0 |
|
| 02/06/2023 |
3
| Duncan Barbara Gayle (Director) has filed a Form 3 on HALOZYME THERAPEUTICS, INC. |
| 01/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|